ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
ABVC BIOPHARMA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.91−0.01 (-0.86%)
Close on Oct 19, 2026
- Market cap
- $23.71M
- P/E (TTM)
- –
- Dividend yield
- –
Abvc Biopharma statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Income (trailing twelve months)
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Operating Income | -$6.52M | -$21.44M |
| Pretax Income | -$7.60M | -$14.45M |
| Net Income | -$7.11M | -$22.46M |
| EBITDA | -$6.52M | -$16.91M |
Returns
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Return on Equity (ROE) | -82.2% | -53.1% |
| Return on Assets (ROA) | -39.9% | -41.0% |
| Return on Invested Capital (ROIC) | -60.6% | -32.0% |
| Return on Capital Employed (ROCE) | -47.5% | -37.8% |
Growth
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -32.7% | 2.25% |
| Revenue Growth (5Y CAGR) | -9.33% | 6.42% |
Balance sheet
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $94.36K | $62.42M |
| Total Debt | $59.46K | $120.13M |
| Net Cash (Debt) | $34.90K | $15.68M |
| Net Cash Per Share | $0.00 | $0.65 |
| Equity (Book Value) | $10.29M | $48.79M |
| Book Value Per Share | $0.39 | $1.36 |
| Tangible Book Value | $10.29M | $23.06M |
| Working Capital | -$5.28M | $75.77M |
Financial position
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Current Ratio | 0.07 | 3.30 |
| Quick Ratio | 0.02 | 2.39 |
| Debt / Equity | 0.01 | 0.51 |
| Interest Coverage | -41.98 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.69M | -$12.35M |
Efficiency
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Profits Per Employee | -$374.03K | -$732.08K |
| Employee Count | 19 | 73 |
Shares
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Shares Outstanding | 26,654,400 | 59,128,900 |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 26,523,200 | 48,744,500 |
| Shares Held by Insiders | 0.49% | 11.8% |
| Shares Held by Institutions | 4.09% | 59.4% |
Scores
| Measure | Abvc Biopharma | Industry median |
|---|---|---|
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Abvc Biopharma's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.